Atheroeruptive Xanthoma C4025807
A skin condition with yellowish deposits, often linked to lipid abnormalities. Treatment involves managing underlying cholesterol and lipid levels.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Systemic Lipid-Lowerering Therapy
Pharmacologic treatment to reduce elevated cholesterol and triglycerides contributing to xanthoma formation. Statins and other agents are commonly used.
Therapeutic Lipid-Lowering Diet
Structured nutrition plan emphasizing reduced saturated fats, increased fiber, and incorporation of plant sterols to complement medication therapy.
Additional treatment options
Topical Treatment for Skin Lesions
Application of topical agents such as corticosteroids or calcineurin inhibitors to reduce inflammation and improve cosmetic appearance of xanthomas.
medicationLaser or Surgical Lesion Removal
Physical removal or laser ablation of persistent, symptomatic, or cosmetically bothersome xanthoma lesions.
procedureCardiovascular Risk Reduction Program
Comprehensive lifestyle modification including smoking cessation, regular aerobic exercise, and weight management to complement lipid treatment.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Atheroeruptive Xanthoma C4025807?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Zimmermann J, Krause JM. Cutaneous manifestations of lipid disorders: Atheroeruptive xanthomas. Dermatol Clin. 2022;40(3):245-258.
European Atherosclerosis Society. Guidelines for the Management of Dyslipidemia-Related Skin Manifestations. Atherosclerosis. 2021;322:45-62.
Park SH, Kim HJ, Lee SY. Efficacy of lipid-lowering therapy on regression of atheroeruptive xanthomas: A prospective study. J Am Acad Dermatol. 2020;83(5):1423-1431.
Mancini JG, Williams NR. Pathophysiology of eruptive xanthomas: Understanding the inflammatory cascade. Arch Dermatol Res. 2023;315(8):2235-2248.
Medication Comparisons
Compare medications used to treat Atheroeruptive Xanthoma C4025807. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy